VeriMomvalprooyl oligopeptide-33 é seguro durante a gravidez?
I could not find authoritative safety or classification data for an ingredient named 'valprooyl oligopeptide-33' in the major cosmetic/regulatory sources. No harmonised CLP classification, SCCS opinion, or CIR assessment for this exact name is available in my training knowledge; therefore default scoring is 0. If this ingredient is an acylated peptide containing a valproyl (valproic acid–derived) group, that parent (valproic acid / sodium valproate) is a known teratogen, but I have no confirmed evidence that this specific cosmetic ingredient is that derivative or that it releases valproic acid in vivo.
Related ingredients
Frequently asked questions
- valprooyl oligopeptide-33 é seguro durante a gravidez?
- I could not find authoritative safety or classification data for an ingredient named 'valprooyl oligopeptide-33' in the major cosmetic/regulatory sources. No harmonised CLP classification, SCCS opinion, or CIR assessment for this exact name is available in my training knowledge; therefore default scoring is 0. If this ingredient is an acylated peptide containing a valproyl (valproic acid–derived) group, that parent (valproic acid / sodium valproate) is a known teratogen, but I have no confirmed evidence that this specific cosmetic ingredient is that derivative or that it releases valproic acid in vivo.
- valprooyl oligopeptide-33 é seguro durante a amamentação?
- No data located in the referenced authoritative sources for breastfeeding-specific effects of 'valprooyl oligopeptide-33'. In absence of documented systemic absorption or reproductive/breastfeeding data, default hazard/exposure scores remain 0. If the ingredient were to liberate valproic acid systemically, breastfeeding concerns would follow those for valproate, but that linkage is not established here.
- valprooyl oligopeptide-33 é seguro para a pele do bebê?
- No specific data for infants (0–3 yr) were found. By default there is no evidence of hazard or mechanism for this ingredient. Because infant skin has higher absorption potential for ingredients that are measurably absorbed in adults, I assign a conservative exposure increase of +1 only if the ingredient has any measurable dermal absorption; however, no data confirming adult absorption were located for this specific ingredient.
- Como o VeriMom pontua valprooyl oligopeptide-33?
- O VeriMom pontua valprooyl oligopeptide-33 em 100/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a valprooyl oligopeptide-33 na gravidez?
- Veja nossa lista curada de alternativas seguras a valprooyl oligopeptide-33 com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.